Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 27;20(5):1403-9.
doi: 10.1002/chem.201303897. Epub 2013 Dec 30.

NAD(P)H-independent asymmetric C=C bond reduction catalyzed by ene reductases by using artificial co-substrates as the hydrogen donor

Affiliations

NAD(P)H-independent asymmetric C=C bond reduction catalyzed by ene reductases by using artificial co-substrates as the hydrogen donor

Christoph K Winkler et al. Chemistry. .

Abstract

To develop a nicotinamide-independent single flavoenzyme system for the asymmetric bioreduction of C=C bonds, four types of hydrogen donor, encompassing more than 50 candidates, were investigated. Six highly potent, cheap, and commercially available co-substrates were identified that (under the optimized conditions) resulted in conversions and enantioselectivities comparable with, or even superior to, those obtained with traditional two-enzyme nicotinamide adenine dinucleotide phosphate (NAD(P)H)-recycling systems.

Keywords: alkene reduction; artificial biocatalysis; ene reductases; enzyme catalysis; hydrogen donors.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Hydrogen-transfer pathways in the bioreduction of C=C bonds activated by an electron-withdrawing group (EWG): indirect hydrogen transfer from a natural hydrogen donor through nicotinamide catalyzed by a dehydrogenase (coupled-enzyme system); nicotinamide-independent direct hydrogen transfer from an artificial hydrogen donor catalyzed by a single ene reductase (coupled-substrate system).
Scheme 2
Scheme 2
Flavoprotein-catalyzed disproportionation of conjugated enones.
Scheme 3
Scheme 3
Screening of four different types of hydrogen donor (1 c–52 c) in the NAD(P)H-independent bioreduction of 4-ketoisophorone (1 a).
Scheme 4
Scheme 4
Co-substrates used as hydrogen donors in the NAD(P)H-independent bioreduction of 4-ketoisophorone (1 a) to form (R)-levodione (1 b) by using OYE1 and XenA enzymes at pH 7.5 and pH 9 (Boc=tert-butoxycarbonyl).

References

    1. Stuermer R, Hauer B, Hall M, Faber K. Curr. Opin. Chem. Biol. 2007;11:203–213. - PubMed
    1. Toogood HS, Gardiner JM, Scrutton NS. ChemCatChem. 2010;2:892–914.
    1. Winkler CK, Tasnadi G, Clay D, Hall M, Faber K. J. Biotechnol. 2012;162:381–389. - PMC - PubMed
    1. Oberdorfer G, Gruber K, Faber K, Hall M. Synlett. 2012;23:1857–1864.
    1. Faber K. Biotransformations in Organic Chemistry. 6. Heidelberg: Springer; 2011. pp. 140–145. th ed.,, pp. .

Publication types

LinkOut - more resources